Summary
The present study compared the effect on insulin sensitivity of ACE inhibitors with a sulphydryl group (captopril) or those without a sulphydryl group (delapril and enalapril) during the hyperinsulinaemic euglycaemic clamp test in both animal and clinical experiments. A possible contribution of bradykinin to the improvement of insulin sensitivity by ACE-inhibition was also studied. In healthy control and depancreatized dog experiments, administration of captopril either intravenously (3.0 mmol · kg−1) or orally (5.0 mmol · kg−1) increased insulin sensitivity indices and plasma bradykinin concentrations. In comparison, intravenous administration of an active metabolite of delapril (3.0 mmol · kg−1) and oral administration of either delapril or enalapril (5.0 mmol · kg−1) showed slight, but not significant increases in insulin sensitivity indices and plasma bradykinin concentrations. Infusion of a bradykinin antagonist (N-α-adamantaneacetyl-d-Arg-[Hyp3, Thi5,8,d-Phe7]-bradykinin) (0.5 nmol · kg−1 · min−1) abolished the effect of captopril on insulin sensitivity. Furthermore, intravenous administration of bradykinin (0.1 nmol · kg−1 · min−1) increased insulin sensitivity indices. In clinical experiments, insulin sensitivity indices decreased in the following order: normotensive healthy subjects, hypertensive non-diabetic patients, normotensive NIDDM patients and hypertensive NIDDM patients. In these four groups, oral administration of captopril (2.0 mmol · kg−1) significantly increased insulin sensitivity indices, and a concomitant increase in plasma bradykinin concentrations was observed. By contrast, oral administration of enalapril or delapril showed slight, but not significant effects on insulin sensitivity indices and plasma bradykinin concentrations. From these studies, it is concluded that ACE inhibitors with a sulphydryl group have more potent action on the improvement in insulin sensitivity than those without a sulphydryl group. Bradykinin may also possibly be involved in the mechanism underlying the improvement in insulin sensitivity associated with ACE-inhibition.
Article PDF
Similar content being viewed by others
Abbreviations
- ACE:
-
Angiotensin converting enzyme
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- IDDM:
-
insulin-dependent diabetes mellitus
- AEP:
-
artificial endocrine pancreas
References
Ferrannini E, Galvan AQ (1992) Hyperinsulinemia, insulin resistance, and blood pressure. Hypertens Res 15: 67–75
Stein PP, Black HR (1991) Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 14: 425–448
Zusman RM (1987) Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity. Am J Kid Dis 10 [Suppl 1]: 13–23
Chobanian AV, Haudenschild CC, Nickerson C, Drago R (1989) Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15: 327–331
Mehta JL, Nicolini FA, Lawson DL (1990) Sulphydryl group in angiotensin converting enzyme inhibitors and Superoxide radical formation. J Cardiovasc Pharmacol 16: 847–849
Gavras H, Gavras I (1988) Angiotensin converting enzyme inhibitors properties and side effects. Hypertension 11 [Suppl II]: 37–41
Rett K, Lotz N, Wicklmayr M et al. (1988) Improved insulin action by ACE inhibitor in type II diabetes. Dtsch Med Wochenschr 113: 243–249
Torlone E, Rambotti AM, Periello G et al. (1991) ACE-in-hibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 34: 119–125
Paolisso G, Gambaldella A, Verza M, D'Amore A, Sgambato S, Varricchio M (1992) ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 6: 175–179
Seefeldt T, Ørskov L, Mengel A et al. (1990) Lack of effects on angiotensin-converting enzyme (ACE)-inhibitors on glucose metabolism in type 1 diabetes. Diabetes Med 7: 700–704
Bak JF, Gerdes LU, Sørensen NS, Pedersen O (1992) Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients. Am J Med 92: 69–72
Moore MP, Elliott TW, Nicholls MG (1988) Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM. Diabetes Care 11: 397–401
Shichiri M, Kawamori R, Abe H (1979) Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes 28: 272–275
Shionoiri H, Yasuda G, Ikeda A et al. (1987) Pharmacokinetics and depressor effect of delapril in patients with essential hypertension. Clin Pharmacol Ther 41: 74–79
Joint National Committee (1988) The 1988 report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 148: 1023–1038
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
Shichiri M, Kawamori R (1985) Optimized algorithms for closed-loop glycemic control systems. In: Beyer J, Albisser M, Schrezenmeir J, Lehmann L (eds) Computer systems for insulin adjustment in diabetes mellitus. Panscienta-Verlag, Hedingen, pp 171–183
Finegood DT, Pacini G, Bergman RN (1984) The insulin sensitivity index: correlation in dogs between values determined from the intravenous glucose tolerance test and the euglycemic glucose clamp. Diabetes 33: 362–368
Minami M, Togashi H, Sano M et al. (1983) Plasma bradykinin concentration in patients with essential hypertension, effort angina and other cardiac disease. Folia Endocrinol Jpn 82: 159–169
Lammek B, Wang Y, Gavras I, Gavras H (1990) A highly potent bradykinin antagonist with no agonist activity. Peptide 11: 1041–1043
DeFronzo RA (1988) Lilly lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 36: 667–687
Ferrannini E, Buzzigoli G, Bonadonna R et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357
Pollare T, Lithell H, Berne C (1989) A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321: 868–873
Bergman RN, Hope ID, Yang YJ et al. (1989) Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 5: 411–429
Patchett AA, Harris E, Tristram EW et al. (1980) A new class of angiotensin-converting enzyme inhibitors. Nature 288: 280–283
O'Hara N, Ono H, Hashimoto K (1982) Potentiation of bradykinin-induced decrease of blood pressure in dogs by SQ 14,551, the disulfide metabolite of captopril. Jpn J Pharmacol 32: 934–937
Drummer OH, Kourtis S, Jarrott B (1985) Inhibition of angiotensin converting enzyme by metabolites of captopril. Clin Exp Pharmacol Physiol [Suppl] 9: 12–16
Drummer OH, Kourtis S (1988) Bradykinin-potentiating activity of captopril disulphide dimer (SQ 14551). Eur J Pharmacol 153: 11–17
Hartl WH, Jauch KW, Herndon DN, Cohnert TU, Wolfe RR, Schidberg FW (1990) Effect of low-dose bradykinin on glucose metabolism and nitrogen balance in surgical patients. Lancet 335: 69–71
Wicklmayr M, Dietze G, Günther B, Boettger I, Mayer L, Janetschek P (1979) Improvement in glucose assimilation and protein degradation by bradykinin in maturity onset diabetics and in surgical patients. Kinins II: 569–576
Laasko M, Edelman V, Brecjtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men. A novel mechanism for insulin resistance. J Clin Invest 85: 1844–1852
Kodama J, Kitayama S, Tanaka K, Itabashi A, Kawazu S, Ishii J (1990) Effect of captopril on glucose concentration: possible role of augmented postprandial forearm blood flow. Diabetes Care 13: 1109–1111
Dietze G (1982) Modulation of the action of insulin in relation to the energy state in skeletal muscle. Possible involvement of kinins and prostaglandins. Mol Cell Endocrinol 25: 127–149
Jauch KW, Günther B, Hartl W, Rett K, Wicklmayr M, Dietze G (1986) Improvement of impaired post-operative insulin action by bradykinin. Biochem Chem Hoppe Seyler 367: 207–210
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uehara, M., Kishikawa, H., Isami, S. et al. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37, 300–307 (1994). https://doi.org/10.1007/BF00398058
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00398058